MK-7246-d3
CAS:
Rif. 3D-TYB91862
Informazioni sul prodotto
MK-7246-d3 is a pancreas-selective β-cell receptor agonist that has been shown to have efficacy in the treatment of type 1 diabetes. The compound is able to inhibit the release of histamine from eosinophilic cells, which may be due to its ability to bind to histamine H1 receptors and inhibit calcium influx. MK-7246-d3 has also been shown to decrease acid secretion and increase bicarbonate secretion. These effects on the pancreas may be due to its ability to act as a potent antagonist at the gastric histamine H2 receptor. MK-7246-d3 has not yet been tested in humans but has shown promising results in vitro and in vivo animal models. This drug is also being evaluated for use in other diseases, such as chronic obstructive pulmonary disease, asthma, and rhinosinusitis.